Bambusa Therapeutics, Inc. (BBTX)

Bambusa Therapeutics will go public soon, but the exact IPO date is still unknown.

Stock Price: Pending

IPO price not available yet

Bambusa Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	Current	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Net Debt / Equity Ratio	-	1.84	0.69
Net Debt / EBITDA Ratio	-	2.21	0.67
Net Debt / FCF Ratio	-	2.28	2.02
Quick Ratio	5.85	9.39	1.00
Return on Equity (ROE)	68.63%	83.56%	101.42%
Return on Assets (ROA)	-	-42.93%	-140.73%
Return on Invested Capital (ROIC)	-	-101.73%	-3098.21%
Return on Capital Employed (ROCE)	399.86%	-47.67%	-3096.43%